DK1243258T3 - Fremstilling og anvendelse af et antibiotikum-/antibiotika-præparat - Google Patents

Fremstilling og anvendelse af et antibiotikum-/antibiotika-præparat

Info

Publication number
DK1243258T3
DK1243258T3 DK02005024T DK02005024T DK1243258T3 DK 1243258 T3 DK1243258 T3 DK 1243258T3 DK 02005024 T DK02005024 T DK 02005024T DK 02005024 T DK02005024 T DK 02005024T DK 1243258 T3 DK1243258 T3 DK 1243258T3
Authority
DK
Denmark
Prior art keywords
sulfonates
cycloalkyl
sulfamates
alkylaryl
aryl
Prior art date
Application number
DK02005024T
Other languages
English (en)
Inventor
Sebastian F Dr Vogt
Matthias Dr Schnabelrauch
Klaus-Dieter Dr Kuehn
Original Assignee
Heraeus Kulzer Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heraeus Kulzer Gmbh & Co Kg filed Critical Heraeus Kulzer Gmbh & Co Kg
Application granted granted Critical
Publication of DK1243258T3 publication Critical patent/DK1243258T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/606—Coatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Transplantation (AREA)
  • Neurosurgery (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK02005024T 2001-03-22 2002-03-06 Fremstilling og anvendelse af et antibiotikum-/antibiotika-præparat DK1243258T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10114245A DE10114245A1 (de) 2001-03-22 2001-03-22 Herstellung und Verwendung einer Antibiotikum-/Antibiotika-Zubereitung

Publications (1)

Publication Number Publication Date
DK1243258T3 true DK1243258T3 (da) 2004-06-21

Family

ID=7678692

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02005024T DK1243258T3 (da) 2001-03-22 2002-03-06 Fremstilling og anvendelse af et antibiotikum-/antibiotika-præparat

Country Status (32)

Country Link
US (1) US20020183265A1 (da)
EP (1) EP1243258B1 (da)
JP (1) JP2002275098A (da)
CN (1) CN1286467C (da)
AT (1) ATE259636T1 (da)
AU (1) AU772160B2 (da)
BG (1) BG65505B1 (da)
BR (1) BR0201099A (da)
CA (1) CA2378503C (da)
CZ (1) CZ2002868A3 (da)
DE (2) DE10114245A1 (da)
DK (1) DK1243258T3 (da)
EE (1) EE200200155A (da)
ES (1) ES2213718T3 (da)
GE (1) GEP20053450B (da)
HR (1) HRP20020242B1 (da)
HU (1) HUP0201043A2 (da)
IL (1) IL148705A (da)
IS (1) IS2499B (da)
MD (1) MD2353C2 (da)
MX (1) MXPA02003006A (da)
NO (1) NO20021389L (da)
NZ (1) NZ517920A (da)
PL (1) PL204985B1 (da)
PT (1) PT1243258E (da)
RU (1) RU2212880C1 (da)
SA (1) SA02230036B1 (da)
SK (1) SK3952002A3 (da)
TR (1) TR200400363T4 (da)
UA (1) UA71993C2 (da)
YU (1) YU11702A (da)
ZA (1) ZA200202255B (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IS6389A (is) 2001-08-31 2003-03-03 Heraeus Kulzer Gmbh & Co. Kg Reynsla af sýklalyfjahúðun skrokka, sem í eru örholrými, og einnig af þannig húðuðum skrokkum og notkun þeirra
IS6390A (is) 2001-08-31 2003-03-03 Heraeus Kulzer Gmbh & Co. Kg Reynsla af sýklalyfjahúðun skrokka sem í eru örholrými, þannig húðuðum skrokkum og einnig af notkunþeirra
DE10262176B4 (de) 2002-06-21 2007-10-04 Heraeus Kulzer Gmbh Verfahren zur Herstellung von antibiotisch beschichteten porösen Körpern sowie Verwendung
DE10318991A1 (de) * 2003-04-25 2004-11-18 Heraeus Kulzer Gmbh & Co. Kg Poröser Körper mit antibiotischer Beschichtung, Verfahren zur Herstellung sowie Verwendung
JP4993465B2 (ja) 2003-12-04 2012-08-08 ユニバーシティ オブ ユタ リサーチ ファウンデーション 変性された高分子ならびにその製造方法および使用方法
DE102004060666B3 (de) 2004-12-15 2006-03-30 Heraeus Kulzer Gmbh Antibiotikum/Antibiotika enthaltendes Knochenersatzmaterial mit retardierender Wirkstofffreisetzung
DE102005002703C5 (de) 2005-01-19 2013-07-04 Heraeus Kulzer Gmbh Antibiotische Beschichtung von Implantaten sowie Verfahren zur antibiotischen Beschichtung
US8685421B2 (en) 2006-07-07 2014-04-01 Surmodics, Inc. Beaded wound spacer device
WO2008100262A1 (en) * 2007-02-16 2008-08-21 Alpharma, Inc. Medicated feed premix comprising chlortetracycline hydrochloride
DE102007063613B4 (de) * 2007-04-24 2010-01-07 Heraeus Kulzer Gmbh Verwendung eines Spacer-Polymethylmethacrylat-Knochenzement
DE102007039871A1 (de) 2007-08-21 2009-02-26 Friedrich-Baur-Gmbh Weichgewebe-Implantat mit antibakterieller Wirkung
CN101225125B (zh) * 2008-01-18 2012-12-05 中国科学院烟台海岸带研究所 一种吸湿保湿剂及其制备方法
US8167836B2 (en) * 2009-12-08 2012-05-01 Taris Biomedical, Inc. Tissue expander configured for drug delivery
DE102010020940B4 (de) * 2010-05-19 2014-09-25 Heraeus Medical Gmbh Antibiotische Beschichtung
WO2013010045A1 (en) 2011-07-12 2013-01-17 Biotime Inc. Novel methods and formulations for orthopedic cell therapy
CN102391954B (zh) * 2011-10-26 2014-12-10 厦门大学 球形棕囊藻培养液的除菌方法
CN102552885A (zh) * 2011-12-16 2012-07-11 青岛海芬海洋生物科技有限公司 海洋生物痔疮及肛内上皮和直肠粘膜上皮细胞消炎修护液
WO2014062839A1 (en) 2012-10-16 2014-04-24 Surmodics, Inc. Wound packing device and methods
RU2540468C2 (ru) * 2012-11-06 2015-02-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Нижегородский государственный университет им. Н.И. Лобачевского"Российская Федерация Способ получения композиционных рассасывающихся материалов на основе хитозана и полилактида
KR102293280B1 (ko) 2013-03-15 2021-08-23 타리스 바이오메디컬 엘엘씨 약물-투과성 구성요소를 가지는 약물 전달 장치 및 방법
US10201457B2 (en) 2014-08-01 2019-02-12 Surmodics, Inc. Wound packing device with nanotextured surface
US10894150B2 (en) 2015-04-23 2021-01-19 Taris Biomedical Llc Drug delivery devices with drug-permeable component and methods
CN105999401B (zh) * 2016-07-22 2019-03-08 武汉理工大学 一种基于羟基磷灰石的牙科抑菌修复材料及其制备方法
CN107459654B (zh) * 2017-08-03 2020-05-26 天津大学 一种模拟抗菌肽共聚物及其制备方法
CN109674806B (zh) * 2019-01-14 2021-10-26 福州奥尼多生物科技有限公司 春雷霉素在制备抗菌药物中的用途

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3091572A (en) * 1962-07-16 1963-05-28 Schering Corp Gentamycin and method of production
ES315101A1 (es) * 1965-07-08 1966-01-01 Folch Vazquez Conrado Procedimiento de preparaciën de nuevos derivados de tetraciclina
ES322771A1 (es) * 1966-02-08 1966-11-16 Folch Vazquez Conrado Procedimiento para la preparaciën de laurilsulfato de tetraciclina
FR6476M (da) * 1967-06-06 1968-11-18
DE2320373B2 (de) * 1973-04-21 1978-04-06 Merck Patent Gmbh, 6100 Darmstadt Antibioticahaltiges Mittel und seine Verwendung als chirurgisches Kunststoffmaterial
FR2272680B1 (da) * 1974-05-29 1978-07-21 Hosbon Sa Lab
AR216922A1 (es) * 1976-11-11 1980-02-15 Merck Patent Gmbh Procedimiento para la fabricacion de un medio quirurgico
DE2843963A1 (de) * 1978-10-09 1980-04-24 Merck Patent Gmbh Im koerper resorbierbare geformte masse auf basis von kollagen und ihre verwendung in der medizin
DE3206725A1 (de) * 1981-05-13 1982-12-02 Merck Patent Gmbh, 6100 Darmstadt Schwer loesliche salze von aminoglykosidantibiotika
DE3248328A1 (de) * 1982-12-28 1984-06-28 Bayer Ag, 5090 Leverkusen Schwerloesliche salze von aminoglykosiden sowie diese enthaltende formulierungen mit verzoegerter wirkstoff-freigabe
US5035891A (en) * 1987-10-05 1991-07-30 Syntex (U.S.A.) Inc. Controlled release subcutaneous implant
FR2668367B1 (fr) * 1990-10-26 1994-05-13 Centre Nal Recherc Scientifique Medicament implantable a effet prolonge.
US5709875A (en) * 1990-10-26 1998-01-20 Centre National De La Rechierche Scientifique (C.N.R.S) Implantable biodegradable material and process for its production
DE4404018A1 (de) * 1994-02-09 1995-08-10 Merck Patent Gmbh Protrahiert freisetzende Darreichungsformen enthaltend Clindamycin-Palmitat
WO1995027517A1 (fr) * 1994-04-06 1995-10-19 Lyzion Australia Pty. Ltd. Preparation pharmaceutique pour application locale, et procede de fabrication
US5614206A (en) * 1995-03-07 1997-03-25 Wright Medical Technology, Inc. Controlled dissolution pellet containing calcium sulfate
US5783217A (en) * 1995-11-07 1998-07-21 Etex Corporation Low temperature calcium phosphate apatite and a method of its manufacture
US5670142A (en) * 1996-07-08 1997-09-23 Donald Neudecker Treatment for itch of chicken pox
US5874418A (en) * 1997-05-05 1999-02-23 Cydex, Inc. Sulfoalkyl ether cyclodextrin based solid pharmaceutical formulations and their use
US5980928A (en) * 1997-07-29 1999-11-09 Terry; Paul B. Implant for preventing conjunctivitis in cattle
US6428579B1 (en) * 1998-07-01 2002-08-06 Brown University Research Foundation Implantable prosthetic devices coated with bioactive molecules
DE10114364A1 (de) * 2001-03-22 2002-10-02 Heraeus Kulzer Gmbh & Co Kg Verfahren zur Herstellung von antibiotischen Kompositen
DE10114244A1 (de) * 2001-03-22 2002-10-02 Heraeus Kulzer Gmbh & Co Kg Antibiotikum-/Antibiotika-Zubereitung mit retardierender Wirkstofffreisetzung

Also Published As

Publication number Publication date
CA2378503C (en) 2008-09-16
ES2213718T3 (es) 2004-09-01
EP1243258B1 (de) 2004-02-18
CZ2002868A3 (cs) 2002-11-13
MD2353C2 (ro) 2004-08-31
AU2756202A (en) 2002-09-26
NO20021389D0 (no) 2002-03-20
HU0201043D0 (da) 2002-05-29
US20020183265A1 (en) 2002-12-05
AU772160B2 (en) 2004-04-08
PL352922A1 (en) 2002-09-23
CN1380064A (zh) 2002-11-20
IL148705A0 (en) 2002-09-12
IS2499B (is) 2009-03-15
EP1243258A1 (de) 2002-09-25
RU2212880C1 (ru) 2003-09-27
IS6271A (is) 2002-09-22
BR0201099A (pt) 2002-11-05
PT1243258E (pt) 2004-07-30
BG65505B1 (bg) 2008-10-31
BG106456A (en) 2002-10-31
IL148705A (en) 2006-12-10
NO20021389L (no) 2002-09-23
NZ517920A (en) 2003-02-28
MXPA02003006A (es) 2003-08-20
JP2002275098A (ja) 2002-09-25
HRP20020242B1 (en) 2005-02-28
HUP0201043A2 (hu) 2003-02-28
SA02230036B1 (ar) 2007-02-27
ATE259636T1 (de) 2004-03-15
TR200400363T4 (tr) 2004-03-22
MD2353B2 (en) 2004-01-31
GEP20053450B (en) 2005-02-25
EE200200155A (et) 2002-12-16
CN1286467C (zh) 2006-11-29
CA2378503A1 (en) 2002-09-22
HRP20020242A2 (en) 2002-12-31
UA71993C2 (en) 2005-01-17
ZA200202255B (en) 2002-10-10
SK3952002A3 (en) 2002-10-08
DE50200244D1 (de) 2004-03-25
PL204985B1 (pl) 2010-02-26
MD20020073A (en) 2002-11-30
DE10114245A1 (de) 2002-10-02
YU11702A (sh) 2004-12-31

Similar Documents

Publication Publication Date Title
DK1243258T3 (da) Fremstilling og anvendelse af et antibiotikum-/antibiotika-præparat
YU11802A (sh) Preparat koji sadrži jedan ili više antibiotika sa usporenim oslobađanjem aktivne supstance i njegova primena
CR6210A (es) Composiciones de celecoxib
CO5050297A1 (es) Uso de peg-ifn-alfa y ribavirina para el tratamiento de hepatitis c cronica
BR0308289A (pt) Antibióticos do tipo florfenicol
JP2008518699A5 (da)
NO20061468L (no) Anvendelse av tigecyklin, alene eller i kombinasjonmed rifampin for behandling av osteomyelitt og/eller septisk artritt
ITMI20022292A1 (it) 9a-azalidi ad attivita' antiinfiammatoria.
FR2886850B1 (fr) Composition a base d'une avermectine et de peroxyde de benzoyle notamment pour le traitement de la rosacee
BRPI0519122A2 (pt) composiÇço oral, e, mÉtodo de reduzir o crescimento de placa bacteriana em uma cavidade oral de um indivÍduo
FR2886852B1 (fr) Composition a base d'une avermectine et d'hydrocortisone notamment pour le traitement de la rosacee
SE0102858D0 (sv) N-type calcium channel antagonists for the treatment of pain
BRPI0415571A (pt) composições de limpeza
BR0202759A (pt) Composição farmacêutica de liberação modificada contendo bupropiona como substância ativa
UA123396U (uk) Фармацевтична композиція у формі вагінальних таблеток для місцевого застосування у гінекології
SE9902673D0 (sv) New composition